Condition
Diabetic Kidney Disease (DKD) clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Diabetic Kidney Disease (DKD) clinical trials that are recruiting, at sites in 4 countries (most in Canada (1), China (1), United States (1)). By phase: Phase 2 (3). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 4Countries
Newest Diabetic Kidney Disease (DKD) clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Goal-Directed Heart, Kidney, and Metabolic Care to Help Adults with Diabetic Kidney Disease | — | Toronto, Ontario | Recruiting | Feb 27, 2026 |
| ANGPTL3 inhibition for adults with diabetic kidney disease | Phase 2 | Huntsville, Alabama and 58 other locations | Recruiting | Dec 9, 2025 |
| Amimestrocel (umbilical cord mesenchymal stromal cells) for diabetic kidney disease | Phase 2 | Beijing, Beijing Municipality and 5 other locations | Recruiting | May 14, 2025 |
| Isuzinaxib for adults with diabetic kidney disease | Phase 2 | Ansan-si and 19 other locations | Recruiting | May 8, 2025 |
All recruiting trials (4)
-
Goal-Directed Heart, Kidney, and Metabolic Care to Help Adults with Diabetic Kidney Disease
This trial tests a structured, early CKM care plan alongside usual care to see if it is feasible and safe for adults with type 2 diabetes and diabetic kidney disease who are at high cardiovascular risk.
-
ANGPTL3 inhibition for adults with diabetic kidney disease
This study tests whether two drugs that block ANGPTL3, ALN-ANG3 and evinacumab, are safe and help adults with type 2 diabetes who have diabetic kidney disease.
-
Amimestrocel (umbilical cord mesenchymal stromal cells) for diabetic kidney disease
This trial will test whether umbilical cord-derived mesenchymal stromal cells (Amimestrocel) can improve kidney function or reduce protein in adults with progressive diabetic kidney disease.
-
Isuzinaxib for adults with diabetic kidney disease
This trial tests whether isuzinaxib (APX-115) is safe and can reduce protein in the urine and protect kidneys in adults with type 2 diabetes and diabetic kidney disease.
Related topics
Quick answers
How many Diabetic Kidney Disease (DKD) clinical trials are recruiting right now?
4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Canada (1 trial), China (1 trial), United States (1 trial), South Korea (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.